Poor 1st-year adherence to anti-osteoporotic therapy increases the risk of mortality in patients with magnetic resonance imaging-proven acute osteoporotic vertebral fractures

References

• GordisLSymposium in honor of Abraham M. Lilienfeld. Chronic disease epidemiology at the threshold of a new decadeAm J Epidemiol198011221691776998285
   PubMed Web of Science ®Google Scholar
• CenterJRBliucDNguyenNDNguyenTVEismanJAOsteoporosis medication and reduced mortality risk in elderly women and menJ Clin Endocrinol Metab20119641006101421289270
   PubMed Web of Science ®Google Scholar
• GeusensPPRouxCHReidDMDrug Insight: choosing a drug treatment strategy for women with osteoporosis-an evidence – based clinical perspectiveNat Clin Prac Rheumatol200845240248
   Google Scholar
• GordisLAssuring the quality of questionnaire data in epidemiologic researchAm J Epidemiol197910912124433912
   PubMed Web of Science ®Google Scholar
• HaynesRBSackettDLTaylorDWHow to detect and manage low patient compliance in chronic illnessGeriatrics1980351919396977350072
   PubMed Web of Science ®Google Scholar
• KripalaniSYaoXHaynesRBInterventions to enhance medication adherence in chronic medical conditions: a systematic reviewArch Intern Med2007167654055017389285
   PubMedGoogle Scholar
• RabendaVMertensRFabriVAdherence to bisphosphonates therapy and hip fracture risk in osteoporotic womenOsteoporos Int200819681181817999022
   PubMed Web of Science ®Google Scholar
• BriesacherBAAndradeSEYoodRAKahlerKHConsequences of poor compliance with bisphosphonatesBone200741588288717707710
   PubMed Web of Science ®Google Scholar
• HuybrechtsKFIshakKJCaroJJAssessment of compliance with osteoporosis treatment and its consequences in a managed care populationBone200638692292816330270
   PubMed Web of Science ®Google Scholar
• SunyeczJAMuchaLBaserOBarrCEAmonkarMMImpact of compliance and persistence with bisphosphonate therapy on health care costs and utilizationOsteoporos Int200819101421142918351427
   PubMed Web of Science ®Google Scholar
• HalpernRBeckerLIqbalSUKazisLEMacariosDBadamgaravEThe association of adherence to osteoporosis therapies with fracture, all-cause medical costs, and all-cause hospitalizations: a retrospective claims analysis of female health plan enrollees with osteoporosisJ Manag Care Pharm2011171253921204588
   PubMed Web of Science ®Google Scholar
• LinWCLuCHChenHLThe impact of preoperative magnetic resonance images on outcome of cemented vertebraeEur Spine J201019111899190620607571
   PubMed Web of Science ®Google Scholar
• CramerJARoyABurrellAMedication compliance and persistence: terminology and definitionsValue Health2008111444718237359
   PubMed Web of Science ®Google Scholar
• ShirakiMKurodaTTanakaSEstablished osteoporosis associated with high mortality after adjustment for age and co-morbidities in postmenopausal Japanese womenIntern Med201150539740421372448
   PubMed Web of Science ®Google Scholar
• IsmailAAO’NeillTWCooperCMortality associated with vertebral deformity in men and women: results from the European Prospective Osteoporosis Study (EPOS)Osteoporos Int1998832912979797915
   PubMed Web of Science ®Google Scholar
• HasseriusRKarlssonMKNilssonBERedlund-JohnellIJohnellOEuropean Vertebral Osteoporosis StudyPrevalent vertebral deformities predict increased mortality and increased fracture rate in both men and women: a 10-year population-based study of 598 individuals from the Swedish cohort in the European Vertebral Osteoporosis StudyOsteoporos Int2003141616812577186
   PubMed Web of Science ®Google Scholar
• JalavaTSarnaSPylkkanenLAssociation between vertebral fracture and increased mortality in osteoporotic patientsJ Bone Miner Res20031871254126012854835
   PubMed Web of Science ®Google Scholar
• NavesMDíaz-LópezJBGómezCRodríguez-RebollarARodríguez-GarcíaMCannata-AndíaJBThe effect of vertebral fracture as a risk factor for osteoporotic fracture and mortality in a Spanish populationOsteoporos Int200314652052412730754
   PubMed Web of Science ®Google Scholar
• NguyenNDAhlborgHGCenterJREismanJANguyenTVResidual lifetime risk of fractures in women and menJ Bone Miner Res200722678178817352657
   PubMed Web of Science ®Google Scholar
• PuistoVRissanenHHeliovaaraMVertebral fracture and cause-specific mortality: a prospective population study of 3,210 men and 3,730 women with 30 years of follow-upEur Spine J201120122181218621611851
   PubMed Web of Science ®Google Scholar
• LauEOngKKurtzSSchmierJEdidinAMortality following the diagnosis of a vertebral compression fracture in the Medicare populationJ Bone Joint Surg Am20089071479148618594096
   PubMed Web of Science ®Google Scholar
• BollandMJGreyABGambleGDReidIREffect of osteoporosis treatment on mortality: a meta-analysisJ Clin Endocrinol Metab20109531174118120080842
   PubMed Web of Science ®Google Scholar
• GreyABollandMJThe effect of treatments for osteoporosis on mortalityOsteoporos Int20132411623076683
   PubMed Web of Science ®Google Scholar
• SirisESHarrisSTRosenCJAdherence to bisphosphonate therapy and fracture rates in osteoporotic women: relationship to vertebral and nonvertebral fractures from 2 US claims databasesMayo Clinic Proc200681810131022
   PubMed Web of Science ®Google Scholar
• CramerJAAmonkarMMHebbornAAltmanRCompliance and persistence with bisphosphonate dosing regimens among women with postmenopausal osteoporosisCurr Med Res Opin20052191453146016197664
   PubMed Web of Science ®Google Scholar
• TuominenOMYlitalo-HeikkalaRVehmasTIMuchaIYlitaloPRiuttaAEffects of bisphosphonates on prostaglandin E2 and thromboxane B2 production in human whole blood and monocytes stimulated by lipopolysaccharide and A23187Methods Find Exp Clin Pharmacol200628636136716894405
   PubMedGoogle Scholar
• BlackDMDelmasPDEastellRHORIZON Pivotal Fracture TrialOnce-yearly zoledronic acid for treatment of postmenopausal osteoporosisN Engl J Med2007356181809182217476007
   PubMed Web of Science ®Google Scholar
• HawkesWGWehrenLOrwigDGender differences in functioning after hip fractureJ Gerontol A Biol Sci Med Sci200661549549916720747
   PubMed Web of Science ®Google Scholar
• WuJSLuCFChouWHHigh prevalence of hepatitis C virus infection in aborigines in TaiwanJpn J Med Sci Biol19924541651741297002
   PubMedGoogle Scholar
• LeeCMChenCHLuSNPrevalence and clinical implications of hepatitis B virus genotypes in southern TaiwanScand J Gastroenterol20033819510112608471
   PubMed Web of Science ®Google Scholar
• LinCFTwuSJChenPHChengJSWangJDPrevalence and determinants of hepatitis B antigenemia in 15,007 inmates in TaiwanJ Epidemiol201020323123620431237
   PubMed Web of Science ®Google Scholar
• BedimoRMaaloufNMLo ReV3rdHepatitis C virus coinfection as a risk factor for osteoporosis and fractureCurr Opin HIV AIDS201611328529326890206
   PubMed Web of Science ®Google Scholar
• ChenCHLinCLKaoCHAssociation between chronic hepatitis b virus infection and risk of osteoporosis: a nationwide population-based studyMedicine20159450e227626683953
   PubMed Web of Science ®Google Scholar
• ChenCHLinCLKaoCHRelation between hepatitis C virus exposure and risk of osteoporosis: a nationwide population-based studyMedicine20159447e208626632720
   PubMed Web of Science ®Google Scholar
• WaalenJBruningALPetersMJBlauEMA telephone-based intervention for increasing the use of osteoporosis medication: a randomized controlled trialAm J Manag Care2009158e60e7019659407
   PubMed Web of Science ®Google Scholar